Medicina · 2022 · 21 citations · 27 references
MedicineHematologyInfectious DiseasesInfectious Disease EpidemiologyMolecular EpidemiologyTransfusion MedicineBlood Group SerologyTransfusion ReactionsTransfusion-transmitted InfectionsRetrospective Case StudyRh Blood Group SystemSerological EpidemiologySerological ProfilingSerological Testing For ImmunityTransfusion Reaction EpidemiologyTransfusion-associated Infection PreventionTransfusion-transmitted Infection Testing
This study was aimed at determining the prevalence estimate and association of transfusion-transmitted infections (TTIs) with ABO and Rh blood groups among blood donors at the King Faisal Specialist Hospital and Research Center (KFSH & RC) in the western region of Saudi Arabia. A retrospective study was conducted at the blood bank center of KFSH and RC from 1 January 2013 to 31 December 2019. Data on ABO and Rh blood group testing, serological testing, molecular investigations, serological assays, nucleic acid testing (NATs), and socio-demographic information were gathered. During the study period, there were 959,431 blood donors at the KFSH and RC. The overall 7-year cumulative prevalence estimate of blood transfusion-transmitted infections among blood donors was low at 7.93%, with an average prevalence estimate of 0.66%. Donors with the O blood group, the O RhD +ve blood group, in particular, were more at risk of developing TTIs, whereas donors with the AB blood group, the AB RhD −ve blood group, in particular, were at the lowest risk of developing TTIs. In total, 96.9% of the blood donors were males (n = 916,567). Almost half of the blood donors belong to the O blood group (49.4%). A total of 861,279 (91.0%) donors were found to be RhD positive. The percentages of TTIs were found to be higher in RhD +ve donors compared with RhD −ve donors. The prevalence estimate of the hemoglobin C (HbC) infection was the most common TTI among the blood donors being 3.97%, followed by malaria being 2.21%. The least prevalence estimate of TTI in the present study was for NAT HIV being 0.02%. Significant associations were observed between RhD +ve and RhD −ve among the malaria-infected donors (A: χ2 = 26.618, p = 0.001; AB: χ2 = 23.540, p = 0.001; B: χ2 = 5.419, p = 0.020; O: χ2 = 68.701, p = 0.001). The current 7-year retrospective study showed a low level of TTIs among blood donors. However, we urge that more research encompassing the entire country be conducted in order to obtain more representative results in terms of the prevalence estimate and association of transfusion-transmitted infections with ABO and Rh blood groups in communities.
27
The Resistance Factor to<i>Plasmodium vivax</i>in Blacks
Louis H. Miller, Steven J. Mason, David F. Clyde et al. · New England Journal of Medicine · 1976 · 1.3K citations
Hepatitis E Virus Antibodies in Blood Donors, France
Jean‐Michel Mansuy, Richard Bendall, Florence Abravanel et al. · Emerging infectious diseases · 2011 · 362 citations · Full text
West Nile Virus among Blood Donors in the United States, 2003 and 2004
Susan L. Stramer, Gregory A. Foster, A.G. Wagner et al. · New England Journal of Medicine · 2005 · 218 citations · Full text
Medicine, Gynecology, Obstetrics +13
The ABO blood group system: historical background
Winifred M. Watkins · Transfusion Medicine · 2001 · 182 citations